Results 231 to 240 of about 665,801 (300)

Defective IL-17 production is associated with reduced IL-1β levels in response to <i>Mycobacterium tuberculosis</i> in HIV+ children with latent tuberculosis infection. [PDF]

open access: yesFront Immunol
Devalraju KP   +11 more
europepmc   +1 more source

TREM2+ Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8+ T Cell Autophagy

open access: yesAdvanced Science, EarlyView.
TREM2+ macrophages are enriched in endometriosis and suppress CD8+ T cell function through SPP1–CD44 communication and BAG3‐associated autophagy regulation. Genetic TREM2 deficiency restores cytotoxic lymphocyte activity, whereas antibody‐mediated TREM2 blockade reduces ectopic lesion growth, highlighting TREM2 as a potential non‐hormonal therapeutic ...
Ming Yuan   +9 more
wiley   +1 more source

In Vivo CRISPR Screen Identifies RPS19 as an Immunotherapy Target in Hepatocellular Carcinoma

open access: yesAdvanced Science, EarlyView.
By employing in vivo CRISPR functional screening, we identify ribosomal protein RPS19 as a pivotal mediator driving immune evasion in hepatocellular carcinoma, wherein tumor‑released RPS19 binds C5aR1 on tumor‑associated macrophages to initiate downstream immunosuppressive signaling; SP94‑peptide‑modified SNPSS nanoparticles deliver Cas9/sgRPS19 ...
Lei He   +20 more
wiley   +1 more source

Combined Immune‐Peptide Nanofiber with HSP70/AKT/mTOR Axis Blockade Enhances Photothermal Immunotherapy, Inhibiting Tumor Growth and Recurrence

open access: yesAdvanced Science, EarlyView.
A carrier‐free peptide‐guided PSP@IR‐CF3 nanofiber system integrates PD‐L1 targeting and photothermal immunotherapy for enhanced cancer treatment. By revealing PTIT‐induced activation of the HSP70/AKT/mTOR pathway and incorporating mTOR inhibition, this strategy effectively overcomes therapeutic resistance and prevents tumor recurrence, providing a ...
Xinyu Zhang   +11 more
wiley   +1 more source

Next-Generation Cancer Nanovaccines: Reprogramming the Tumor Microenvironment from Rational Design Toward Clinical Translation. [PDF]

open access: yesInt J Nanomedicine
Tabibzadeh S   +7 more
europepmc   +1 more source

BRCA1 Mutation‐Recognizing Tetrahedral Framework Nucleic Acid Nanoplatform Enables Coordinated PARP/WEE1 Inhibition and STING‐Associated Antitumor Immunity in Ovarian Cancer

open access: yesAdvanced Science, EarlyView.
BRCA1 mutation‐responsive FBOA‐tFNA selectively recognizes mutant transcripts and coordinates reduction‐responsive intracellular delivery of olaparib and adavosertib, amplifying DNA damage and weakening G2/M checkpoint protection. These effects are accompanied by STING‐associated immune activation and stronger antitumor immunity, while sequential anti ...
Chenyi Wang   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy